HBK Investments’s Amicus Therapeutics FOLD Stock Holding History

HBK Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,783,448	Closed	-$127M	–	326
2026 Q1	$127M	Sell	8,783,448 -6,466,552	-42%	-$92.7M	1.29%	22
2025 Q4	$217M	Buy	+15,250,000	New	+$150M	1.71%	19
2015 Q4	–	Sell	-91,300	Closed	-$1.28M	–	1022
2015 Q3	$1.28M	Buy	+91,300	New	+$1.43M	0.01%	525

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HBK Investments's FOLD Position: Q2 2026 in Review

HBK Investments sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 8,783,448 shares — an estimated $127M sold.

HBK Investments first reported a position in FOLD in Q3 2015 and held it in 3 quarters. The position peaked at $217M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

HBK Investments reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
HBK Investments sold 8,783,448 Amicus Therapeutics shares in Q2 2026, an estimated $127M.
HBK Investments first reported a position in Amicus Therapeutics in Q3 2015 and held it in 3 quarters.
HBK Investments's Amicus Therapeutics position peaked at $217M in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on HBK Investments's 13F filing for Q2 2026, filed 14 Aug 2026.